Participants were enrolled from the Eye and ENT Hospital, Fudan University, Shanghai, China, from May to July 2015. The subjects enrolled in this study had visually significant cataracts but no other eye diseases, and had been admitted for phacoemulsification surgery with IOL implantation. If both of the subject's eyes qualified for the study, only the first operation eye was enrolled. This research was approved by the Institutional Review Board and followed the tenets of the Declaration of Helsinki. All subjects signed informed consent forms.
Exclusion criteria included eyes with glaucoma (glaucomatous visual loss or optic neuropathy determined by optic disc cupping); a preoperative IOP > 21 mm Hg; a narrow or closed AC angle (Shaffer classification with a grade of 0 or 1, at least two quadrants); and pseudoexfoliation syndrome. Also excluded were those with a history of ocular trauma or intraocular surgery; corneal abnormalities, including scarring, dystrophy, and corneal opacity; uveitis; severe retinal diseases; and intraoperative or postoperative complications caused by cataract surgery. The use of topical or systemic medications that might influence the IOP measurements was also grounds for exclusion.
All the subjects who were enrolled in this study underwent complete ophthalmologic examinations, including best-corrected visual acuity (BCVA) in logMAR, slit-lamp biomicroscopy, and cataract grading lens opacities classification III (LOCS III). The subjects also had refraction measurements using an autorefractor (NIDEK ARK-700A, Aichi, Japan), which was further refined by an experienced optometrist, followed by a calculation of the spherical equivalent (SE) using the spherical diopter (D) plus one-half of the cylindrical dioptric power. The corneal K value was also obtained using the same autorefractor. Furthermore, subjects received a dilated fundus examination using a three-mirror contact lens; IOP was measured using Goldmann applanation tonometry by a single trained ophthalmologist (WH); and axial length (AL) measurement was performed using an IOLmaster (Carl Ziess, Inc., Jena, Germany). Gonioscopy was performed using a gonioscope (Volk G-1 trabeculum; Volk Optical, Inc., Mentor, OH, USA), and the angle was given Shaffer grades by an ophthalmologist (XZ). Each patient's medical and family histories were also collected. Measurements of the OCT, AL, IOP, K value, and BCVA were obtained before the phacoemulsification surgery. The OCT, BCVA, K value, and IOP measurements were also obtained 1 day, 1 week, 1 month, and 6 months after surgery.